Results 81 to 90 of about 599,112 (261)
A Personalised Vaccination Program Based on Immune Reconstitution in Paediatric Cancer Survivors
ABSTRACT Aims Paediatric cancer survivors often experience treatment‐induced immunosuppression, requiring post‐treatment revaccination. However, immune recovery timelines vary, and current revaccination guidelines, largely based on data of varied quality derived from studies on acute‐lymphoblastic‐leukaemia (ALL), may not be applicable across all ...
Menucha Jurkowicz +17 more
wiley +1 more source
In this retrospective cohort of adult Burkitt lymphoma, DA‐EPOCH‐R showed no signal of inferior survival or relapse risk compared with GMALL‐based high‐intensity therapy. Outcomes were driven mainly by established prognostic factors, particularly age, advanced stage and Burkitt lymphoma International Prognostic Index.
Eduard Schulz +4 more
wiley +1 more source
Antiproliferative and proapoptotic effects of extract on Burkitt lymphoma cell line
Burkitt lymphoma is a very aggressive B-cell non-Hodgkin lymphoma. Although remarkable progress has been made in the therapeutic scenario for patients with Burkitt lymphoma, search and development of new effective anticancer agents to improve patient ...
Patrizia Virdis +15 more
doaj +1 more source
Intussusception in a 4-Year-Old Male Due to Burkitt Lymphoma
Intussusception is the invagination of a proximal bowel segment into a distal segment causing bowel obstruction, especially in children. In some cases, it can be caused by a pathological lead point, such as Burkitt lymphoma.
Raed Al-Taher +3 more
doaj +1 more source
Pleiotropic Roles of FBXO11 in Tumorigenesis: Implications for Targeted Therapy
This complex comprises of scaffold CUL1, SKP1, RBX1 and FBXO11 receptor. The substrate is phosphorylated by specific kinase enzyme and recognized by the substrate recognition domain. FBXO11 targets numerous substrates for ubiquitination and degradation, FBXO11 substrates mainly include Snail, ZEB1, p53, BCL6, CDT2, CIITA, Cdc25a, hnRNPA2B1, SAMD1 and ...
Yuqi Zhang +6 more
wiley +1 more source
The Authors report a case of Burkitt's lymphoma of the stomach in a patient treated ten years before for Hodgkin's lymphoma. Gastrectomy associated to chemotherapy is more effective than surgical treatment alone and avoids the risk of gastric perforation during medical treatment.
SANTORO G, ROCCO, PASQUALE
openaire +2 more sources
Primary Gastric Atypical Burkitt Lymphoma: A Rare Case Report
The abdomen, particularly the ileocecal region, is the most commonly affected disease site in sporadic Burkitt lymphoma (BL). Involvement of the stomach is very rare.
Jing Zheng MD +6 more
doaj +1 more source
Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics
Burkitt’s lymphoma (BL) can often be cured by intensive chemotherapy, but the toxicity of such therapy precludes its use in the elderly and in patients with endemic BL in developing countries, necessitating new strategies.
R. Schmitz +41 more
semanticscholar +1 more source
ABSTRACT Aberrant expression of T‐cell markers in B‐cell lymphomas is rare and can pose diagnostic challenges. We report a case of a 65‐year‐old man presenting with newly developed scalp nodules. Histopathology revealed nodular lymphoid infiltrates composed of large centrocytes and centroblasts.
V. Pfefferle +4 more
wiley +1 more source
Burkitt Lymphoma of the Duodenum: An Uncommon Phenomenon
Burkitt lymphoma is an aggressively growing tumor commonly found in African children, involving the jaw and facial bones. Most non-Hodgkin lymphoma tumors involve extra nodal sites like the nervous system and gastrointestinal tract.
Fahad Malik +2 more
doaj +1 more source

